Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check9 days agoChange DetectedThe clinical trial record for vedolizumab with antiretroviral therapy in HIV-infected participants is displayed, with study design, eligibility, contacts, and outcome details.SummaryDifference48%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check30 days agoChange DetectedA sitewide NIH notice was added, announcing updates to terminology around artificial intelligence during a transition period.SummaryDifference1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.